Cargando…
Metabolomics Contributions to the Discovery of Prostate Cancer Biomarkers
Prostate cancer (PCa) is one of the most frequently diagnosed cancers and a leading cause of death among men worldwide. Despite extensive efforts in biomarker discovery during the last years, currently used clinical biomarkers are still lacking enough specificity and sensitivity for PCa early detect...
Autores principales: | Gómez-Cebrián, Nuria, Rojas-Benedicto, Ayelén, Albors-Vaquer, Arturo, López-Guerrero, José Antonio, Pineda-Lucena, Antonio, Puchades-Carrasco, Leonor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468766/ https://www.ncbi.nlm.nih.gov/pubmed/30857149 http://dx.doi.org/10.3390/metabo9030048 |
Ejemplares similares
-
Polycythemia Vera and Essential Thrombocythemia Patients Exhibit Unique Serum Metabolic Profiles Compared to Healthy Individuals and Secondary Thrombocytosis Patients
por: Gómez-Cebrián, Nuria, et al.
Publicado: (2021) -
Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches
por: Gómez-Cebrián, Nuria, et al.
Publicado: (2022) -
Metabolomics Applications in Precision Medicine: An Oncological Perspective
por: Puchades-Carrasco, Leonor, et al.
Publicado: (2017) -
Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia
por: Pérez-Rambla, Clara, et al.
Publicado: (2017) -
Active and prospective latent tuberculosis are associated with different metabolomic profiles: clinical potential for the identification of rapid and non-invasive biomarkers
por: Albors-Vaquer, A., et al.
Publicado: (2020)